Cell surface markers are protein or antigenic determinants found on the surface of specific types of cells. They also act as a marker for identifying the specific type of cell. Determination of ligands or drug response in research activities is done through cell surface marker analysis.
The factors that drive the growth of this market are advancement in healthcare technology and growing inclination towards minimizing healthcare expenditure by reducing the cost associated with diagnosis. However, complex products and expensive instruments and reagents used in cell marker analysis have restricted the market growth.
Global Cell Surface Marker Market by Instrument and Reagents types
Global cell surface marker market is segmented by type into flow Cytometer, hematology analyzer, reagents and kits. The main equipment used for cell marker analysis is flow Cytometer and hematology analyzers. Flow Cytometer is the most widely used instrument due to availability of a variety of flow cytometers. Flow cytometers have proved to be efficacious in drug discovery as well as in research, which further fuels their demand.
Global Cell Surface Marker Market by Application
Global cell surface marker market is segmented by application into disease diagnosis and research and drug discovery. Cell surface marker application in research and drug discovery is expected to dominate the market as cell marker analysis is widely used by pharmaceutical manufacturers and researchers in their research and development process and o in drug discovery.
Global Cell Surface Marker Market by Geography
Geographically, the market is segmented into North America, Europe, Asia-Pacific and LAMEA. North America dominates the cell surface marker market due to the significant amount of research and development activities in this region and the well-developed healthcare infrastructure. Asia-Pacific and LAMEA are the fastest growing regions due to growing demand for targeted therapies which are safe and easy to use, and development in healthcare infrastructure.
Bio-Rad, Abbott Laboratories, Seimens Healthcare, Beckman Coulter, Roche Diagnostics, BD Biosciences and Nihon Kohden Corporation are some key players in this market. Partnerships, product launch, merger & acquisition, research and development are the competitive strategies adopted by these players. In April 2014, Beckman Coulter Life Sciences announced the acquisition of Xitogen Technologies, a cytometer manufacturer. This acquisition helps Beckman Coulter to broaden its product offerings and enables business expansion in Asia.
According to Porter’s Five Forces analysis, the bargaining power of the supplier is high as products are highly differentiated. High switching cost leads to the low bargaining power of buyers. Threat from substitutes is low as few substitutes are available in the market. Many competitors with high exit barriers lead to intense competition in the market. Threat from new entrants is low as brand names are well known and profitability requires economies of scale. SWOT analysis helps in determining the internal and external environmental factors, which would help in strategic business planning. Analysis of key players and their strategies help in developing a market entry and expansion strategy.
Quantitative analysis of the current market scenario as well as the future estimations through 2013-2020 would help stakeholders understand the future prospects of the market.
Market intelligence for key developmental strategies adopted by top companies is explained with impact analysis.
The report analyzes the factors that are driving and limiting the growth of market.
Analysis of trends in various regions would help the companies to plan their strategies depending on the regions.
The market is segmented based on instrument and reagent type, application and geography.
MARKET BY INSTRUMENT AND REAGENT TYPE
Reagents and Kits
MARKET BY APPLICATION
Research and Drug Discovery
MARKET BY GEOGRAPHY
* This report will be delivered in 12 Business Days. *